Article info
PDFColon
Original article
Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
- Correspondence to Professor Robert Benamouzig, Department of Gastroenterology, AP-HP, Hôpital Avicenne, 125 route de Stalingrad, 93009 Bobigny, France; robert.benamouzig{at}avc.aphp.fr
Citation
Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
Publication history
- Revised May 24, 2011
- Accepted June 2, 2011
- First published September 2, 2011.
Online issue publication
December 24, 2011
Article Versions
- Previous version (2 September 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.